What does CARDOLITE SPECIALTY CHEMICALS EUROPE do?

CARDOLITE SPECIALTY CHEMICALS EUROPE is a wholesaler in Gent. Public Limited, started on 10 February 2011, 1 establishment.

What is the address of CARDOLITE SPECIALTY CHEMICALS EUROPE?

The registered office of CARDOLITE SPECIALTY CHEMICALS EUROPE is located at Wijmenstraat 21K box 2, 9030 Gent.

Is CARDOLITE SPECIALTY CHEMICALS EUROPE still active?

Yes. According to the CBE (31 October 2026) CARDOLITE SPECIALTY CHEMICALS EUROPE is active, legal situation “Normale toestand”, started on 10 February 2011.

Is CARDOLITE SPECIALTY CHEMICALS EUROPE registered on Peppol?

Yes, CARDOLITE SPECIALTY CHEMICALS EUROPE is registered on the Peppol network with ID 0208:0833642744.

What is the enterprise number of CARDOLITE SPECIALTY CHEMICALS EUROPE?

The enterprise number of CARDOLITE SPECIALTY CHEMICALS EUROPE is BE0833642744.

When was CARDOLITE SPECIALTY CHEMICALS EUROPE founded?

CARDOLITE SPECIALTY CHEMICALS EUROPE was founded on 10 February 2011.

Who are the directors of CARDOLITE SPECIALTY CHEMICALS EUROPE?

According to the 2025 annual accounts, the directors of CARDOLITE SPECIALTY CHEMICALS EUROPE are: Timothy Joseph Stonis, Andrew Thomas Bose.

Is CARDOLITE SPECIALTY CHEMICALS EUROPE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 10 February 2011; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did CARDOLITE SPECIALTY CHEMICALS EUROPE make in 2025?

CARDOLITE SPECIALTY CHEMICALS EUROPE posted a profit after taxes of € 651,961 in financial year 2025.

What is the revenue of CARDOLITE SPECIALTY CHEMICALS EUROPE?

In its most recent annual accounts (2025), CARDOLITE SPECIALTY CHEMICALS EUROPE reported revenue of € 29,311,198.

How much does an employee at CARDOLITE SPECIALTY CHEMICALS EUROPE earn?

The average wage cost per full-time employee at CARDOLITE SPECIALTY CHEMICALS EUROPE was € 126,400 in 2025: staff costs of € 480,375 for 3.8 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does CARDOLITE SPECIALTY CHEMICALS EUROPE have?

According to the 2025 annual accounts, CARDOLITE SPECIALTY CHEMICALS EUROPE has 3.8 full-time equivalents (FTE).

CARDOLITE SPECIALTY CHEMICALS EUROPE (Public Limited)

Dossier CARDOLITE SPECIALTY CHEMICALS EUROPE, printed on 1 November 2026 from databakkes.be/en/0833642744/cardolite-specialty-chemicals-europe. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

CARDOLITE SPECIALTY CHEMICALS EUROPE from Gent, company number BE0833642744, closed financial year 2025 with a result of € 651,961 after tax. For that financial year CARDOLITE SPECIALTY CHEMICALS EUROPE recorded revenue of € 29.3 million and equity of € 3 million. Compared with financial year 2024, the result moved from € 679,647 to € 651,961. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 6, 2026.

What it is worth Growing

€ 3 million

▲ 28% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 651,961

▼ 4% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 1.3 million

▼ 4% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 3 million.

People and assets in 2025

Full-time equivalents

3.8

Average over the fiscal year, from the social balance sheet.

Wage cost Staff costs are payroll only. Director pay sits with services and miscellaneous goods: € 2.1 million in 2025, together with rent, insurance, accountants and other services. The accounts do not split that further.

€ 480,375

▲ 1% vs 2024

€ 126,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 8,026

▲ 49% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 1.3 million

▼ 9% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 9.3 million

▲ 57% vs 2024

Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 123 days on average.

Taxes and wages

€ 893,305

▲ € 808,163 vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Revenue	€ 30,412,051 Revenue 2022: € 30,412,051 First fiscal year in the series	€ 29,574,832 Revenue 2023: € 29,574,832 ▼ 3% vs 2022 (€ 30,412,051) Unfavourable step	€ 29,321,562 Revenue 2024: € 29,321,562 ▼ 1% vs 2023 (€ 29,574,832) Unfavourable step	€ 29,311,198 Revenue 2025: € 29,311,198 Unchanged (€ 29,321,562) Unfavourable step
Profit after taxes	€ 856,022 Profit after taxes 2022: € 856,022 First fiscal year in the series	€ 455,995 Profit after taxes 2023: € 455,995 ▼ 47% vs 2022 (€ 856,022) Unfavourable step	€ 679,647 Profit after taxes 2024: € 679,647 ▲ 49% vs 2023 (€ 455,995) Favourable step	€ 651,961 Profit after taxes 2025: € 651,961 ▼ 4% vs 2024 (€ 679,647) Unfavourable step	▼ 4%
Equity	€ 1,234,560 Equity 2022: € 1,234,560 First fiscal year in the series	€ 1,690,555 Equity 2023: € 1,690,555 ▲ 37% vs 2022 (€ 1,234,560) Favourable step	€ 2,370,202 Equity 2024: € 2,370,202 ▲ 40% vs 2023 (€ 1,690,555) Favourable step	€ 3,022,163 Equity 2025: € 3,022,163 ▲ 28% vs 2024 (€ 2,370,202) Favourable step	▲ 28%
Total debts	€ 11,183,388 Total debts 2022: € 11,183,388 First fiscal year in the series	€ 7,893,910 Total debts 2023: € 7,893,910 ▼ 29% vs 2022 (€ 11,183,388) Favourable step	€ 7,451,689 Total debts 2024: € 7,451,689 ▼ 6% vs 2023 (€ 7,893,910) Favourable step	€ 11,614,747 Total debts 2025: € 11,614,747 ▲ 56% vs 2024 (€ 7,451,689) Unfavourable step	▲ 56%
Cash	€ 481,392 Cash 2022: € 481,392 First fiscal year in the series	€ 1,233,008 Cash 2023: € 1,233,008 ▲ 156% vs 2022 (€ 481,392) Favourable step	€ 1,306,516 Cash 2024: € 1,306,516 ▲ 6% vs 2023 (€ 1,233,008) Favourable step	€ 1,251,754 Cash 2025: € 1,251,754 ▼ 4% vs 2024 (€ 1,306,516) Unfavourable step	▼ 4%
Retained profit	€ 1,173,060 Retained profit 2022: € 1,173,060 First fiscal year in the series	€ 1,629,055 Retained profit 2023: € 1,629,055 ▲ 39% vs 2022 (€ 1,173,060) Favourable step	€ 2,308,702 Retained profit 2024: € 2,308,702 ▲ 42% vs 2023 (€ 1,629,055) Favourable step	€ 2,960,663 Retained profit 2025: € 2,960,663 ▲ 28% vs 2024 (€ 2,308,702) Favourable step	▲ 28%
Bank debt	€ 1,406,338 Bank debt 2022: € 1,406,338 First fiscal year in the series	€ 1,356,852 Bank debt 2023: € 1,356,852 ▼ 4% vs 2022 (€ 1,406,338) Favourable step	€ 1,420,186 Bank debt 2024: € 1,420,186 ▲ 5% vs 2023 (€ 1,356,852) Unfavourable step	€ 1,296,905 Bank debt 2025: € 1,296,905 ▼ 9% vs 2024 (€ 1,420,186) Favourable step	▼ 9%
Balance sheet total	€ 12,417,948 Balance sheet total 2022: € 12,417,948 First fiscal year in the series	€ 9,584,465 Balance sheet total 2023: € 9,584,465 ▼ 23% vs 2022 (€ 12,417,948) Unchanged	€ 9,821,892 Balance sheet total 2024: € 9,821,892 ▲ 2% vs 2023 (€ 9,584,465) Unchanged	€ 14,636,910 Balance sheet total 2025: € 14,636,910 ▲ 49% vs 2024 (€ 9,821,892) Unchanged	▲ 49%
Employees (FTE)	3.5 Employees (FTE) 2022: 3.5 First fiscal year in the series	3.8 Employees (FTE) 2023: 3.8 ▲ 0.3 vs 2022 (3.5) Unchanged	3.8 Employees (FTE) 2024: 3.8 Unchanged (3.8) Unchanged	3.8 Employees (FTE) 2025: 3.8 Unchanged (3.8) Unchanged

Key figures of CARDOLITE SPECIALTY CHEMICALS EUROPE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to CARDOLITE SPECIALTY CHEMICALS EUROPE?

What happened at CARDOLITE SPECIALTY CHEMICALS EUROPE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2031 Andrew Thomas Bose stepped down as director. NBB
2030 Timothy Joseph Stonis stepped down as director. NBB
Jul 6, 2026 New annual accounts for financial year 2025: profit of € 651,961 (▼ 4% vs 2024). Source: NBB ↗
2025 Andrew Thomas Bose became a director. NBB
2024 Timothy Joseph Stonis became a director. NBB
Feb 10, 2011 Start of the company according to the CBE. KBO
Feb 9, 2011 New establishment in Gent. KBO

In short

From € 856,022 profit in 2022 to € 651,961 profit in 2025.

Paid € 1.5 million in corporate taxes since 2022.

Best year ever: 2022, with € 856,022 profit.

Pays suppliers within 123 days on average.

Original PDFs at the National Bank ↗

Management

CARDOLITE SPECIALTY CHEMICALS EUROPE

AEP POLYMERS SRL 100%

It owns 100% of AEP POLYMERS SRL itself.

Directors

According to the 2025 annual accounts

Timothy Joseph Stonis

Managing director

since 2024 · until 2030

Andrew Thomas Bose

Director

since 2025 · until 2031

Establishments

Establishment units

Physical locations of this company

Registered office

Wijmenstraat 21K box 2

9030 Gent

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0833.642.744

VAT number

BE 0833.642.744

Registered office

Wijmenstraat 21K bus 2, 9030 Gent

Names & denominations

CARDOLITE SPECIALTY CHEMICALS EUROPE

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

10 February 2011

Peppol

Active · Active since 5 Dec 2025

Activities · NACE

Groothandel in chemische producten voor industrieel gebruik

Groothandel in behang, verf en woningtextiel

View on CBE Public ↗ Annual accounts (NBB) ↗

CARDOLITE SPECIALTY CHEMICALS EUROPE

Financials

What happened to CARDOLITE SPECIALTY CHEMICALS EUROPE?

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions